Research institutes and funding agencies in central and eastern Europe assess policies and strategies to help close the research and innovation divide with the west
Pharmaceutical strategy aims to boost EU drug discovery and prevent medicines shortages. Some MEPs want to go further and force companies to invest more of their profits in R&D and agree to flexible IP rules. Others say that is ‘tone deaf’
Universities and research institutes urge science publishers to stop imposing embargoes on manuscripts funded by agencies that make open access a condition of public grants
Agenda for first meeting of research ministers since last September – and first since member states approved Horizon Europe legislation - does not feature discussion of repeated delays in fully launching the programme
With a struggle to attract foreign talent due to low salaries, and pandemic-driven economic crisis sparking cuts in national science budgets, researchers in EU13 countries are puzzling over how to tap new research programme to strengthen R&D systems
Romania was to be a founding member of the new consortium, but a long-standing political wrangle over equipment contract and operational autonomy has now prompted the Czech Republic and Hungary to move forward alone
Commission must explain how it can achieve technological autonomy without a clearer plan, and a stricter timeline for launching new technologies by 2030, MEPs say
MEPs and research organisations say more needs to be done to align the strategy with research and innovation funding programmes over the next seven years
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.